Zheng Su
Private Equity Investor presso Deerfield Management Co. LP (Private Equity)
Profilo
Zheng Su, Ph.D., is a Partner on the Therapeutics team.
Between 2013 and 2021, Dr. Su spent over eight years at Deerfield in roles of increasing responsibility.
Following a brief absence, he returned to the Firm in 2022.
Prior to Deerfield, he was a Senior Statistical Scientist at Genentech, an Assistant Professor at SUNY Stony Brook, and a Visiting Assistant Professor at Stanford University.
He was formerly Editor-in-Chief of Contemporary Clinical Trials and Co-Editor-in-Chief of Contemporary Clinical Trials Communications.
Dr. Su holds a B.S.
in Mathematics from Peking University, as well as an M.S.
in Financial Mathematics and a Ph.D.
in Computational Mathematics and Statistics from Stanford University, where he also received his post-doctoral training in biostatistics.
He has published over 50 articles on the design and analysis of clinical trials.
Posizioni attive di Zheng Su
Società | Posizione | Inizio |
---|---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Private Equity Investor | 01/01/2013 |
Formazione di Zheng Su
Stanford University | Doctorate Degree |
Peking University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Finance |
- Borsa valori
- Insiders
- Zheng Su